ZBH · 8-K · 20260805PR333761

Revenue Performance and Mix

ZIMMER BIOMET HOLDINGS, INC. · 2026-08-05 · Importance 42 · Surprise 14 · No source text

Second-quarter 2026 net sales were $2.177 billion, up 4.8% reported, 4.7% on a constant-currency basis and 4.0% on an organic constant-currency basis year over year. United States sales increased 5.6% to $1,239.9 million, while international sales increased 3.7% to $937.0 million. Technology & Data, Bone Cement and Surgical sales rose 21.1% to $199.4 million, and S.E.T. sales rose 6.4% to $586.0 million, while Knees increased 0.4% to $828.9 million and Hips increased 5.0% to $562.7 million. For the first six months, sales increased 7.0% to $4.264 billion, led by S.E.T. growth of 12.5% and Technology & Data, Bone Cement and Surgical growth of 18.0%.

Key facts

• Three months Technology & Data, Bone Cement and Surgical net sales: $199.4 million, reported change 21.1%, constant currency 21.5%, organic constant currency 21.5% source
• Second quarter net sales: $2.177 billion, increased 4.8% on a reported basis, 4.7% on a constant currency basis and 4.0% on an organic constant currency basis source
• Six months net sales: $4,263.7 million (for the six months ended June 30, 2026) source
• Three months S.E.T. net sales: $586.0 million, reported change 6.4%, constant currency 6.2%, organic constant currency 3.4% source

Impact estimates